ANET vs PFE: Which Is the Better Buy?
Side-by-side comparison of Arista Networks, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Arista Networks, Inc. · Technology
$172.62
+12.4% upside to fair value
Grade C
High Quality
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ANET |
PFE |
| Current Price |
$172.62 |
$26.33 |
| Fair Value Estimate |
$193.98 |
$33.85 |
| Upside to Fair Value |
+12.4%
|
+28.6%
|
| Market Cap |
$217.4B |
$149.8B |
| Forward P/E |
61.8x
|
19.3x
|
| EV / EBITDA |
54.8x
|
12.9x
|
| Price / Sales |
24.1x
|
2.4x
|
| Price / FCF |
51.1x
|
16.5x
|
| Revenue Growth YoY |
+28.9%
|
-1.2%
|
| Gross Margin |
64.1%
|
70.3%
|
| Operating Margin |
42.8%
|
24.7%
|
| Return on Equity |
31.0%
|
8.7%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.96%
|
6.06%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Arista Networks is a leading provider of software-driven cloud networking solutions focused on AI, cloud, and data center markets. The company benefits from durable competitive advantages including a highly experienced leadership team led by CEO Jayshree Ullal, who has driven growth from startup to a $100 billion market cap S&P 500 company. Arista's business quality is high, supported by strong r…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
ANET |
PFE |
| Zone Low |
$145.48 |
$25.39 |
| Zone High |
$164.88 |
$28.77 |
| In Buy Zone? |
No
|
Yes
|